Alkem Laboratories Limited (ALKEM)
Pl find enclosed unaudited financial results along with LRR for quarter ended 30th June, 2026
Q1FY27 results (unaudited):
Standalone:
Revenue 26.7bn +12% y-y (23.7bn)
EBITDA 7.7bn +20% y-y (6.4bn)
EBITDA margin 27.2% (25.7%) +150 bps y-y
PAT 5.7bn -13% y-y (6.6bn)
Consolidated:
Revenue 37.4bn +11% y-y (33.7bn)
EBITDA 7.7bn +4% y-y (7.4bn)
EBITDA margin 20.5% (21.9%) -140 bps y-y
PAT 5.2bn -22% y-y (6.6bn)
Dividend: None stated
Commentary: The company reported steady growth in India and international businesses with strong domestic market outperformance and double-digit growth in non-US international markets. Investments in R&D, MedTech and Biotech continue as part of growth strategy.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 ALKEM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add ALKEM to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Alkem Laboratories Limited
Important.
The summary above is generated automatically from Alkem Laboratories Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.